Safety Study for NST-001 and the Neuroject Injection Set to Treat Tinnitus

Inclusion Criteria: * Patients able to provide voluntary consent. * Severe tinnitus in one ear that began no more than ten years ago. * Ear to be treated must be deaf or have profound hearing loss. * Subjects with cardiac disease or hypertension, must have stable disease for at least 6 months. * Subject must have intact cochlear nerve on the ear to be treated. * Women of childbearing potential (i.e., not post-menopausal or surgically sterilized) must agree to use adequate birth control methods as recommended by the study physician. Exclusion Criteria: * Current diagnosis of bilateral tinnitus. * Current diagnosis or history of pancreatitis. * Females that are pregnant or lactating. * Use of investigational drugs within the previous 30 days. * History of drug dependency or other substance abuse.